Zkušenosti s neinvazivní prenatální diagnostiku – test Clarigo
| STAŇO KOZUBÍK, Kateřina, Ivona BLAHÁKOVÁ, Jana JEDLIČKOVÁ, Šárka POSPÍŠILOVÁ and Boris TICHÝ. Zkušenosti s neinvazivní prenatální diagnostiku – test Clarigo (Experience with non-invasive prenatal diagnostics - Clarigo test). In RANK – Rutinní analýza nukleových kyselin. 2017. |
|
Other formats:
BibTeX
LaTeX
RIS
|
| Basic information | |
|---|---|
| Original name | Zkušenosti s neinvazivní prenatální diagnostiku – test Clarigo |
| Name (in English) | Experience with non-invasive prenatal diagnostics - Clarigo test |
| Authors | STAŇO KOZUBÍK, Kateřina (203 Czech Republic, belonging to the institution), Ivona BLAHÁKOVÁ (203 Czech Republic, belonging to the institution), Jana JEDLIČKOVÁ (203 Czech Republic, belonging to the institution), Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution) and Boris TICHÝ (203 Czech Republic, belonging to the institution). |
| Edition | RANK – Rutinní analýza nukleových kyselin, 2017. |
| Other information | |
|---|---|
| Original language | Czech |
| Type of outcome | Conference abstract |
| Field of Study | 10606 Microbiology |
| Confidentiality degree | is not subject to a state or trade secret |
| RIV identification code | RIV/00216224:14740/17:00097805 |
| Organization unit | Central European Institute of Technology |
| Keywords in English | Clarigo; experience |
| Tags | rivok |
| Changed by | Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 28/3/2018 11:26. |
| Abstract |
|---|
| Zkušenosti s neinvazivní prenatální diagnostiku – test Clarigo. Neinvazivní prenatální test Clarigo je určen ke skríningu aneuploidií chromozómů 21, 18 a 13 u plodu s využitím analýzy volné DNA (cfDNA) získané ze vzorku krve těhotné ženy. Pohlaví plodu je stanoveno průkazem DNA chromozómu Y (tato možnost je volitelná). |
| Abstract (in English) |
|---|
| Experience with non-invasive prenatal diagnostics - Clarigo test. Non-invasive prenatal Clarigo test is designed to screen aneuploidy of chromosomes 21, 18 and 13 in the fetus using free DNA analysis (cfDNA) obtained from a blood sample of a pregnant woman. The fetus sex is determined by DNA chromosome detection (this option is optional). |
| Links | |
|---|---|
| LM2015091, research and development project | Name: Národní centrum lékařské genomiky (Acronym: NCLG) |
| Investor: Ministry of Education, Youth and Sports of the CR | |
| LQ1601, research and development project | Name: CEITEC 2020 (Acronym: CEITEC2020) |
| Investor: Ministry of Education, Youth and Sports of the CR | |
PrintDisplayed: 21/8/2024 12:57